查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1551287

2030 年组织工程市场预测：按产品类型、技术、应用、最终用户和地区分類的全球分析

Tissue Engineering Market Forecasts to 2030 - Global Analysis By Product (Scaffolds, Cell Culture, Hydrogels, 3D Bioprinting and Other Products), Material Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2024年全球组织工程市场规模将达51亿美元，预计2030年将达到134亿美元，预测期内复合年增长率为17.3%。

组织工程是一个跨学科领域，结合生物学和工程学的原理，创造生物替代品，以恢復、维持和改善受损组织和器官的功能。这个过程通常使用细胞、支架和生化因子来开发用于医疗应用的可行组织结构。组织工程涵盖多种技术和应用，包括皮肤、软骨和器官修復，在再生医学中发挥重要作用。

根据 2022 年 5 月发表的一项题为「脊髓损伤女性的性和浪漫经历：印度背景的见解」的研究，估计全球每年约有 25 万至 50 万人经历脊髓损伤 (SCI)。

对再生医学的需求不断增长

对再生医学不断增长的需求是市场的主要驱动因素。慢性病、器官衰竭和组织损伤的日益普及正在推动对组织工程提供的再生疗法的需求。组织工程旨在透过使用细胞和支架开发生物替代品来恢復、维持和改善组织功能。这个跨学科领域结合了生物学和工程学原理，为皮肤、软骨和器官修復等医学应用创建可行的组织结构。

製造扩充性

製造可扩展性给市场带来了重大挑战，并对市场成长潜力产生了负面影响。大规模製造组织工程产品的复杂性往往会导致品质和性能的变化，从而阻碍监管部门的核准和市场进入。因此，技术创新的步伐将会放缓，医疗保健市场中组织工程解决方案的整体可用性将会下降，进而影响患者的治疗结果和治疗选择。

医疗保健支出增加

由于其具有减少手术侵入性和缩短恢復时间等优点，组织支架的使用也正在增加。这项投资是为了满足对器官衰竭、退化性疾病和创伤等疾病的创新治疗日益增长的需求。随着医疗保健系统优先考虑具有成本效益的长期解决方案，该市场正在加速成长。总的来说，这些因素都有助于组织工程和再生解决方案市场的扩大。

治疗费用高

所使用的先进技术，如生物材料、生长因子、活细胞、支架和功能基质，使得组织工程治疗对患者来说昂贵。这限制了取得和采用，特别是在人口众多但医疗预算有限的发展中地区。克服高治疗成本带来的经济障碍对于市场充分发挥潜力并为更多患者群体带来再生解决方案至关重要。

COVID-19 的影响：

COVID-19 透过加速再生疗法的研究和加强对病毒引起的严重组织损伤的解决方案的开发来影响市场。此次疫情凸显了对先进组织修復技术的需求，并刺激了对相关研究的投资。然而，它也造成了供应链和临床试验的中断。总体而言，疫情加剧了组织工程创新的迫切性，同时为生产和开发时间表带来了挑战。

脚手架部分预计将成为预测期内最大的部分

预计脚手架在预测期内将达到最高水准。这些构建体可以由合成或生物衍生材料製成，旨在模拟自然组织的细胞外基质。支架透过促进细胞增殖和分化来促进骨骼、软骨和皮肤等各种组织的再生。 3D 列印和水凝胶等技术创新正在增强支架设计，并为再生医学中复杂的组织修復和再生需求提供更有效和客製化的解决方案。

预计脱细胞细分市场在预测期内复合年增长率最高。

预计去细胞化领域在预测期内将出现最高的复合年增长率。该技术创建了一个支持细胞附着和生长、促进组织再生的支架。当使用患者特异性细胞进行再细胞化时，去细胞支架有利于保留天然生化线索和机械特性并促进更大的完整性和功能。这种方法增加了成功组织修復的可能性，并已应用于多个领域，包括再生医学和器官移植。

比最大的地区

预计北美在预测期内将占据最大的市场占有率。由于主要企业的强大影响力和支持组织工程创新的有利政府政策，该地区占据了主导市场占有率。该地区先进的医疗基础设施和高支出进一步鼓励采用创新的组织工程解决方案，以满足许多患有退化性疾病和损伤的患者的需求。

复合年增长率最高的地区：

由于医疗保健需求的增长、再生医学的进步以及慢性病患病率的增加，预计亚太地区在预测期内将保持最高的复合年增长率。该地区的主要参与者正在投资新技术和方法，以增强组织再生并应对组织特异性材料开发等挑战。不断增长的老年人口和政府改善医疗基础设施的努力进一步推动了这个充满活力的地区的市场扩张。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球组织工程市场：依产品

  • 鹰架
  • 细胞培养
  • 水凝胶
  • 3D生物列印
  • 其他产品

第六章全球组织工程市场：依材料类型

  • 合成材料
  • 生物材料
  • 复合材料
  • 生物陶瓷

第七章全球组织工程市场：依技术分类

  • 静电纺丝
  • 冷冻保存
  • 去细胞化
  • 基因编辑
  • 再生医学
  • 其他技术

第八章全球组织工程市场：依应用分类

  • 整形外科
  • 神经病学
  • 心血管
  • 皮肤和体被
  • 牙科
  • 其他用途

第九章全球组织工程市场：依最终使用者分类

  • 医院/诊所
  • 研究实验室
  • 学术机构
  • 其他最终用户

第十章全球组织工程市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • Athersys Inc.
  • Osiris Therapeutics Inc.
  • Cytori Therapeutics Inc.
  • Vericel Corporation
  • Regenative Labs LLC
  • MiMedx Group Inc.
  • TissueTech Inc.
  • Stryker Corporation
  • Celgene Corporation
  • Medtronic plc
  • Amgen Inc.
  • Thermo Fisher Scientific Inc.
  • Corning Inc.
  • Glycosan BioSystems Inc.
  • Centrica Inc.
  • Arthrex Inc.
Product Code: SMRC27070

According to Stratistics MRC, the Global Tissue Engineering Market is accounted for $5.1 billion in 2024 and is expected to reach $13.4 billion by 2030 growing at a CAGR of 17.3% during the forecast period. Tissue engineering is a multidisciplinary field that combines principles from biology and engineering to create biological substitutes aimed at restoring, maintaining, or improving the function of damaged tissues or organs. This process often involves using cells, scaffolds, and biochemical factors to develop viable tissue constructs for medical applications. Tissue engineering encompasses a variety of techniques and applications, including the repair of skin, cartilage, and organs, and plays a crucial role in regenerative medicine

According to a research study titled "Sexuality and relationship experiences of women with spinal cord injury: reflections from an Indian context", published in May 2022, it is estimated that approximately 250,000-500,000 people worldwide experience a spinal cord injury (SCI) annually.

Market Dynamics:

Driver:

Growing need for regenerative medicines

The growing need for regenerative medicines is a key driver of the market. Increasing prevalence of chronic diseases, organ failures, and tissue damage is fueling demand for regenerative therapies that tissue engineering can provide. Tissue engineering aims to restore, maintain, or improve tissue function by developing biological substitutes using cells, scaffolds. This multidisciplinary field combines principles from biology and engineering to create viable tissue constructs for medical applications like skin, cartilage, and organ repair.

Restraint:

Manufacturing scalability

Manufacturing scalability poses significant challenges in the market, negatively affecting its growth potential. The complexity of producing tissue-engineered products at scale often leads to inconsistencies in quality and performance, which can hinder regulatory approval and market entry. This results in a slower pace of innovation and reduces the overall availability of tissue-engineered solutions in the healthcare market, impacting patient outcomes and treatment options.

Opportunity:

Rising healthcare expenditure

The adoption of tissue scaffolds is also on the rise due to their benefits like reduced surgical invasiveness and faster recovery times. This investment addresses the growing demand for innovative treatments for conditions like organ failure, degenerative diseases, and traumatic injuries. As healthcare systems prioritize cost-effective, long-term solutions, the market sees accelerated growth. These factors collectively contribute to the expanding market for tissue engineering and regeneration solutions.

Threat:

High treatment cost

The advanced technologies used, including biomaterials, growth factors, living cells, scaffolds, and functional matrices, make tissue engineering treatments expensive for patients. This limits accessibility and adoption, especially in developing regions with large populations but limited healthcare budgets. Overcoming the financial barriers posed by high treatment costs will be crucial for the market to reach its full potential and provide regenerative solutions to a wider patient population.

Covid-19 Impact:

COVID-19 has impacted the market by accelerating research into regenerative therapies and enhancing focus on developing solutions for severe tissue damage caused by the virus. The pandemic has highlighted the need for advanced tissue repair technologies and driven investments in related research. However, it also caused disruptions in supply chains and clinical trials. Overall, the pandemic has increased urgency for innovations in tissue engineering while presenting challenges in production and development timelines.

The scaffolds segment is expected to be the largest during the forecast period

The scaffolds is expected to be the largest during the forecast period. These structures can be made from synthetic or biologically derived materials, designed to mimic the extracellular matrix of natural tissues. Scaffolds facilitate the regeneration of various tissues, including bone, cartilage, and skin, by promoting cell proliferation and differentiation. Innovations such as 3D printing and hydrogels are enhancing scaffold design, enabling more effective and tailored solutions for complex tissue repair and regeneration needs in regenerative medicine.

The decellularized segment is expected to have the highest CAGR during the forecast period

The decellularized segment is expected to have the highest CAGR during the forecast period. This technique creates scaffolds that can support cell attachment and growth, facilitating tissue regeneration. Decellularized scaffolds are advantageous as they retain natural biochemical cues and mechanical properties, promoting better integration and functionality when recellularized with patient-specific cells. This approach enhances the potential for successful tissue repair and has applications in various fields, including regenerative medicine and organ transplantation.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The region holds a dominant market share, driven by a robust presence of leading companies, and favorable government policies supporting innovation in tissue engineering. The region's advanced healthcare infrastructure and high spending further enhance the adoption of innovative tissue engineering solutions, addressing the needs of a large patient population suffering from degenerative conditions and injuries.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period driven by rising healthcare demands, advancements in regenerative medicine, and an increasing prevalence of chronic diseases. Key players in the region are investing in new technologies and methodologies to enhance tissue regeneration, addressing challenges such as the development of tissue-specific materials. The increasing geriatric population and government initiatives to improve healthcare infrastructure further support market expansion in this dynamic region.

Key players in the market

Some of the key players in Tissue Engineering market include Athersys Inc., Osiris Therapeutics Inc., Cytori Therapeutics Inc., Vericel Corporation, Regenative Labs LLC, MiMedx Group Inc., TissueTech Inc., Stryker Corporation, Celgene Corporation, Medtronic plc, Amgen Inc., Thermo Fisher Scientific Inc., Corning Inc., Glycosan BioSystems Inc., Centrica Inc. and Arthrex Inc.

Key Developments:

In April 2024, Medtronic plc announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra(TM) valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management. It's an excellent choice for cardiac surgeons and their patients seeking an aortic valve solution that can be fit for the future, right from the start.

In January 2024, Arthrex has launched a new patient-focused resource, TheNanoExperience.com, highlighting the science and benefits of Nano arthroscopy, a modern, least-invasive orthopedic procedure that may allow for a quick return to activity and less pain.

Products Covered:

  • Scaffolds
  • Cell Culture
  • Hydrogels
  • 3D Bioprinting
  • Other Products

Material Types Covered:

  • Synthetic Materials
  • Biological Materials
  • Composite Materials
  • Bioceramics

Technologies Covered:

  • Electrospinning
  • Cryopreservation
  • Decellularization
  • Gene Editing
  • Regenerative Medicine
  • Other Technologies

Applications Covered:

  • Orthopedics
  • Neurology
  • Cardiovascular
  • Skin & Integumentary
  • Dental
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Research Laboratories
  • Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Tissue Engineering Market, By Product

  • 5.1 Introduction
  • 5.2 Scaffolds
  • 5.3 Cell Culture
  • 5.4 Hydrogels
  • 5.5 3D Bioprinting
  • 5.6 Other Products

6 Global Tissue Engineering Market, By Material Type

  • 6.1 Introduction
  • 6.2 Synthetic Materials
  • 6.3 Biological Materials
  • 6.4 Composite Materials
  • 6.5 Bioceramics

7 Global Tissue Engineering Market, By Technology

  • 7.1 Introduction
  • 7.2 Electrospinning
  • 7.3 Cryopreservation
  • 7.4 Decellularization
  • 7.5 Gene Editing
  • 7.6 Regenerative Medicine
  • 7.7 Other Technologies

8 Global Tissue Engineering Market, By Application

  • 8.1 Introduction
  • 8.2 Orthopedics
  • 8.3 Neurology
  • 8.4 Cardiovascular
  • 8.5 Skin & Integumentary
  • 8.6 Dental
  • 8.7 Other Applications

9 Global Tissue Engineering Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Research Laboratories
  • 9.4 Academic Institutes
  • 9.5 Other End Users

10 Global Tissue Engineering Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Athersys Inc.
  • 12.2 Osiris Therapeutics Inc.
  • 12.3 Cytori Therapeutics Inc.
  • 12.4 Vericel Corporation
  • 12.5 Regenative Labs LLC
  • 12.6 MiMedx Group Inc.
  • 12.7 TissueTech Inc.
  • 12.8 Stryker Corporation
  • 12.9 Celgene Corporation
  • 12.10 Medtronic plc
  • 12.11 Amgen Inc.
  • 12.12 Thermo Fisher Scientific Inc.
  • 12.13 Corning Inc.
  • 12.14 Glycosan BioSystems Inc.
  • 12.15 Centrica Inc.
  • 12.16 Arthrex Inc.

List of Tables

  • Table 1 Global Tissue Engineering Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Tissue Engineering Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Tissue Engineering Market Outlook, By Scaffolds (2022-2030) ($MN)
  • Table 4 Global Tissue Engineering Market Outlook, By Cell Culture (2022-2030) ($MN)
  • Table 5 Global Tissue Engineering Market Outlook, By Hydrogels (2022-2030) ($MN)
  • Table 6 Global Tissue Engineering Market Outlook, By 3D Bioprinting (2022-2030) ($MN)
  • Table 7 Global Tissue Engineering Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 8 Global Tissue Engineering Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 9 Global Tissue Engineering Market Outlook, By Synthetic Materials (2022-2030) ($MN)
  • Table 10 Global Tissue Engineering Market Outlook, By Biological Materials (2022-2030) ($MN)
  • Table 11 Global Tissue Engineering Market Outlook, By Composite Materials (2022-2030) ($MN)
  • Table 12 Global Tissue Engineering Market Outlook, By Bioceramics (2022-2030) ($MN)
  • Table 13 Global Tissue Engineering Market Outlook, By Technology (2022-2030) ($MN)
  • Table 14 Global Tissue Engineering Market Outlook, By Electrospinning (2022-2030) ($MN)
  • Table 15 Global Tissue Engineering Market Outlook, By Cryopreservation (2022-2030) ($MN)
  • Table 16 Global Tissue Engineering Market Outlook, By Decellularization (2022-2030) ($MN)
  • Table 17 Global Tissue Engineering Market Outlook, By Gene Editing (2022-2030) ($MN)
  • Table 18 Global Tissue Engineering Market Outlook, By Regenerative Medicine (2022-2030) ($MN)
  • Table 19 Global Tissue Engineering Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 20 Global Tissue Engineering Market Outlook, By Application (2022-2030) ($MN)
  • Table 21 Global Tissue Engineering Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 22 Global Tissue Engineering Market Outlook, By Neurology (2022-2030) ($MN)
  • Table 23 Global Tissue Engineering Market Outlook, By Cardiovascular (2022-2030) ($MN)
  • Table 24 Global Tissue Engineering Market Outlook, By Skin & Integumentary (2022-2030) ($MN)
  • Table 25 Global Tissue Engineering Market Outlook, By Dental (2022-2030) ($MN)
  • Table 26 Global Tissue Engineering Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 27 Global Tissue Engineering Market Outlook, By End User (2022-2030) ($MN)
  • Table 28 Global Tissue Engineering Market Outlook, By Hospitals & Clinics (2022-2030) ($MN)
  • Table 29 Global Tissue Engineering Market Outlook, By Research Laboratories (2022-2030) ($MN)
  • Table 30 Global Tissue Engineering Market Outlook, By Academic Institutes (2022-2030) ($MN)
  • Table 31 Global Tissue Engineering Market Outlook, By Other End Users (2022-2030) ($MN) (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.